Vincent Trudeau1, Giorgio Gandaglia2, Jonas Shiffmann3, Ioana Popa1, Shahrokh F Shariat4, Francesco Montorsi5, Paul Perrotte6, Quoc-Dien Trinh7, Pierre I Karakiewicz8, Maxine Sun1. 1. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC; 2. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC; ; Department of Urology, Vita-Salute, San Raffaele University Milan, Italy; 3. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC; ; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany; 4. Department of Urology, Medical University of Vienna, Vienna, Austria; 5. Department of Urology, Vita-Salute, San Raffaele University Milan, Italy; 6. Department of Urology, University of Montreal Health Centre, Montreal, QC; 7. Department of Surgery, Division of Urology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. 8. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC; ; Department of Urology, University of Montreal Health Centre, Montreal, QC;
Abstract
INTRODUCTION: We compared short-term outcomes and costs between robotic-assisted nephroureterectomy (RANU) and laparoscopic radical nephroureterectomy (LNU) in a large population-based cohort of patients with upper-tract urothelial carcinoma (UTUC). METHODS: Overall, 1914 patients with UTUC treated with RANU or LNU between 2008 and 2010 within the Nationwide Inpatient Sample were abstracted. Propensity-score matching was performed to account for inherent differences between patients undergoing RANU and LNU. Multivariable logistic regression models were fitted to compare postoperative complications, blood transfusions, prolonged length of stay, and costs between the 2 procedures. RESULTS: Overall, a weighted estimate of 1199 (62.6%) and 715 (37.4%) patients received LNU and RANU, respectively. In multivariable analyses no significant differences were observed in postoperative transfusion and length of stay between the 2 surgical approaches (all p > 0.1). However, patients undergoing RANU were less likely to experience any complications compared to their counterparts undergoing LNU (p = 0.04). The utilization of RANU was associated with substantially higher costs compared to the laparoscopic approach. Our study is limited by its retrospective nature and the lack of adjustment for tumour stage and grade. CONCLUSIONS: Our results support the safety and feasibility of RANU for the treatment of UTUC. Indeed, the use of the robotic approach was associated with lower probability of experiencing perioperative complications compared to LNU. On the other hand, the utilization of RANU is associated with higher costs compared to LNU.
INTRODUCTION: We compared short-term outcomes and costs between robotic-assisted nephroureterectomy (RANU) and laparoscopic radical nephroureterectomy (LNU) in a large population-based cohort of patients with upper-tract urothelial carcinoma (UTUC). METHODS: Overall, 1914 patients with UTUC treated with RANU or LNU between 2008 and 2010 within the Nationwide Inpatient Sample were abstracted. Propensity-score matching was performed to account for inherent differences between patients undergoing RANU and LNU. Multivariable logistic regression models were fitted to compare postoperative complications, blood transfusions, prolonged length of stay, and costs between the 2 procedures. RESULTS: Overall, a weighted estimate of 1199 (62.6%) and 715 (37.4%) patients received LNU and RANU, respectively. In multivariable analyses no significant differences were observed in postoperative transfusion and length of stay between the 2 surgical approaches (all p > 0.1). However, patients undergoing RANU were less likely to experience any complications compared to their counterparts undergoing LNU (p = 0.04). The utilization of RANU was associated with substantially higher costs compared to the laparoscopic approach. Our study is limited by its retrospective nature and the lack of adjustment for tumour stage and grade. CONCLUSIONS: Our results support the safety and feasibility of RANU for the treatment of UTUC. Indeed, the use of the robotic approach was associated with lower probability of experiencing perioperative complications compared to LNU. On the other hand, the utilization of RANU is associated with higher costs compared to LNU.
Authors: Morgan Rouprêt; Marko Babjuk; Eva Compérat; Richard Zigeuner; Richard Sylvester; Max Burger; Nigel Cowan; Andreas Böhle; Bas W G Van Rhijn; Eero Kaasinen; Joan Palou; Shahrokh F Shariat Journal: Eur Urol Date: 2013-03-19 Impact factor: 20.096
Authors: Jae Won Lee; Francis Raymond P Arkoncel; Koon Ho Rha; Kyung Hwa Choi; Ho Song Yu; Yunbyung Chae; Woong Kyu Han Journal: J Endourol Date: 2011-09 Impact factor: 2.942
Authors: William T Lowrance; James A Eastham; David S Yee; Vincent P Laudone; Brian Denton; Peter T Scardino; Elena B Elkin Journal: Cancer Date: 2011-10-24 Impact factor: 6.860
Authors: Hiten D Patel; Jeffrey K Mullins; Phillip M Pierorazio; Gautam Jayram; Jason E Cohen; Brian R Matlaga; Mohamad E Allaf Journal: J Urol Date: 2012-10-17 Impact factor: 7.450
Authors: Ruben De Groote; Karel Decaestecker; Alessandro Larcher; Sarah Buelens; Elise De Bleser; Frederiek D'Hondt; Peter Schatteman; Nicolaas Lumen; Francesco Montorsi; Alexandreμ Mottrie; Geert De Naeyer Journal: J Robot Surg Date: 2019-04-30
Authors: Thomas Stonier; Nick Simson; Su-Min Lee; Ian Robertson; Tarik Amer; Bhaskar K Somani; Bhavan P Rai; Omar Aboumarzouk Journal: Arab J Urol Date: 2017-06-16